Uncategorized
What an ER doctor and musical trendsetter Miri Ben-Ari, a Jay Z collaborator, have in common
Being a successful musician is a lot like being a trauma room physician. You need to collaborate harmoniously with others, practice a lot and perform expertly in real time.
One might think that performing on some of the world’s largest stages and at high-profile venues like the White House is nothing like working in a tight space in a hospital emergency room. One involves art, the other science; one happens in public, the other behind closed doors; one appears beautiful and clean, the other can be messy and bloody. But the two actually have a lot in common.
Dr. Tal Patalon, the head of Kahn Sagol Maccabi (KSM), the Research and Innovation Center of the Israeli HMO Maccabi Healthcare Services, highlighted this when she hosted Grammy Award-winning violinist, producer and UN Goodwill Ambassador of Music Miri Ben-Ari on her podcast, “A Matter of Life and Death.”
“It is as though I am meditating on the highest frequency when I am in front of a live audience,” Ben-Ari said. “It is like an out-of-body experience.”
Patalon, an active clinician specializing in family and emergency medicine, said, “The same thing happens to me when a patient comes in. Every decision is one of life and death. You have to be in the moment. You have to give your everything to perform at your max.”
Musical trendsetter Ben-Ari has brought the violin to the fore in commercial pop music, collaborating with artists including John Legend, Alicia Keys, Janet Jackson and Jay Z.
The unusual and popular podcast — now in its third season, but the first in English — is an opportunity for Patalon to talk with thought leaders from a wide variety of backgrounds and fields, including medicine, academia, technology and the corporate world, and she brings to listeners unusual conversations that wind their way from the esoteric to the profound. Recent guests on the program have included astrophysicist Avi Loeb, former Mossad chief Yossi Cohen, and psychologist and happiness expert Tal Ben-Shahar.
KSM has unique access to Maccabi’s professional medical data and conducts medical research, helping scientists, tech companies and entrepreneurs through various partnerships; uses a unique cloud-based platform that relies in part on AI technology; operates a bio-bank with over 1 million biological samples that assist companies in genetic sequencing and genetic research; and supports a range of other big data and clinical research projects.
Patalon thinks broadly, seeking inspiration from all corners.
Born in Tel Aviv, violinist Ben-Ari, 44, grew up playing classical music and at one point studied under the legendary Israeli violinist Isaac Stern.
“But something switched for me when I heard a recording of Charlie Parker,” Ben-Ari said. “He wasn’t playing the saxophone; he was talking to it. I wanted to do that with the violin. So I studied jazz in the United States and played with the best.”
Ben-Ari, who remained in the United States and lives in New Jersey, felt she was finally in her zone. “Now I could do me. I could integrate, harmonize and collaborate,” she said.
Miri Ben-Ari, left, was a guest of Dr. Tal Patalon, the head of Kahn Sagol Maccabi (KSM), the Research and Innovation Center of the Israeli HMO Maccabi Healthcare Services, on her podcast “A Matter of Life and Death.” (Courtesy of KSM Research and Innovation Center)
Over the past two years, Ben-Ari has branched out even further by working with African artists such as Nigerian producer Young D and Tanzanian superstar Diamond Platumz, who plays bongo flava — a melange of American hip hop and traditional Tanzanian styles.
“It’s been fascinating working with African artists,” Ben-Ari said. “Africa is so close to Israel, so it was natural for me to go in this direction. The music is different in each country, and in each region of the continent.”
Patalon asked Ben-Ari on her podcast what it has been like to move from classical music training to experimentation with so many genres.
“I actually gave a TED talk about how to take a skill from one place to another,” Ben-Ari said. “You first have to have a firm foundation, then you can let your imagination take over and think outside the box.”
But it’s not easy, she said. “You find your own individual way of expression. It takes a lot of chutzpah, drive, persistence, dedication and bravery to keep continuing when you get a lot of no’s along the way.”
According to Patalon, the process bears some similarities to medicine. Just as Ben-Ari had to have years of classical training behind her to be able to innovate as she does, trauma care doctors need to have their basics intact before trying new approaches, Patalon said. One can only innovate on top of a deep foundation of expertise, experience and competence.
“It’s more than just knowing the basics. You need to be able to do them as an automatic response behavior. I need to know how to resuscitate a patient with my eyes closed and one hand tied behind my back,” she said. “We have to be experts.”
At the end of every podcast episode, Patalon asks her guest whether they think about death and how they would like to be remembered.
Ben-Ari said that the prospect of death doesn’t regularly occupy her: “I am busy with life, and I don’t think about what will happen after I die.”
When Patalon asked Ben-Ari what she would like the epitaph on her gravestone to say, she said she didn’t want an actual place of burial.
“I don’t believe in graves,” Ben Ari said. “I want to be an NFT or something technological like that. I would want there to be one private one just for my child, and a different version for my fans.”
Patalon suggested that she wasn’t surprised that Ben-Ari doesn’t think much about death, noting how common it is for people to fear death because they fear pain and losing relationships with loved ones — and are afraid of the unknown.
In the last episode of her popular podcast, Patalon offers some intriguing insights into the future of medical treatment: how technology will help predict a person’s medical future, how therapies can be tailored to the individual’s level, and the ethical questions that arise from these advances.
Ultimately, Patalon concludes, our well-being will be determined by what we do outside medical establishments: “I hope that we will all learn how to take the time to introspect, to develop relationships that are meaningful, because at the end of the day that’s what really keeps us happy.”
To listen to this episode and others from Season 3, visit ksminnovation.com/podcast.
—
The post What an ER doctor and musical trendsetter Miri Ben-Ari, a Jay Z collaborator, have in common appeared first on Jewish Telegraphic Agency.
Uncategorized
Staunch Israel supporter Coons expected to win Delaware Democratic Senate primary handily
(JTA) — Delaware incumbent Sen. Chris Coons, a longtime supporter of Israel, is expected to easily win Delaware’s U.S. Senate primary on Tuesday, despite criticism from party progressives.
Coons, a mainstay of the Senate Foreign Relations Committee, has repeatedly backed measures to bolster Israel’s capacity for self-defense. He also joined a bipartisan delegation to visit Israel immediately after the October 7, 2023, Hamas attacks.
But the senator has faced pushback in recent months for his refusal to back measures that would cut military aid to Israel.
This past spring, he was one of just seven Democrats to join Republicans in voting against a resolution authored by independent Vermont Sen. Bernie Sanders, which sought to stop the sale of military bulldozers to Israel. Coons was among just 11 Democrats who opposed a second Sanders resolution that proposed similar sales bans on massive bombs and other defense equipment.
Coons has served nearly three terms in the Senate. He won a special election in 2010, about a year after Joe Biden resigned to become U.S. vice president, and then went on to secure two full terms in 2014 and 2020.
In Tuesday’s primary, he will face off against artificial intelligence systems builder and historian Jeff Appelhans, naval architect and marine engineer Mary Louve and a former business executive who changed his legal name from Eric Hansen to E. No-Trump Hansen.
While Coons has earned endorsements from establishment Democrats, such as Delaware Sen. Lisa Blunt Rochester and Gov. Matt Meyer, he has drawn criticism from party progressives for both his support of Israel and the financial backing he gets from the American Israel Public Affairs Committee, the pro-Israel lobbying group.
Of Coons’s opponents, the most vocal critic on Israel-related policy has been Appelhans, whose campaign priorities included ending U.S. support for Israel’s war in Gaza. Appelhans slammed Coons for voting against the Sanders bills, writing on his campaign site that “the liberal consensus moved to block the sales.”
Appelhans condemned Coons’s voting record on “moving armaments to Israel,” noting in a recent interview that “there’s never been a vote that he’s stopped” on this issue. He was speaking with Delaware Public Media last week as part of a series of candidate interviews.
Regarding the conflict in Iran, Appelhans slammed “Congress’ unwillingness” to challenge the president, noting that “there was very much a sense that Israel would be a staunch ally and they could sort of get this done really easily.”
In the same radio series, another candidate, Louve, expressed uncertainty as to “why we’re still backing Israel,” while acknowledging the country’s history as a U.S. ally.
“Is it worth us continuing to step up for a bully?” she asked. “It’s aggression that is unnecessary that’s continuing to escalate because we’re helping it.”
Hansen did not participate in these conversations, Delaware Public Media stated.
This summer Coons pledged to stop taking donations from the data company Palantir, which has come under scrutiny for its work with the Israel’s Defense Ministry, the U.S. military and U.S. Immigration and Customs Enforcement, according to the nonprofit news site Spotlight Delaware.
Despite his more centrist reputation, Coons has had significant criticism for the Trump administration’s strategies in Iran. In his own Delaware Public Media interview, Coons accused the president of selling the conflict “as a cheap, quick war.”
While little polling data was available ahead of Tuesday’s race, the Polymarket predictions site gave Coons a 99.7% chance of winning as of Monday evening. In his last primary in 2020, Coons defeated a progressive opponent, Jessica Scarane, with nearly 73% of voter support.
Regardless of Tuesday’s outcome, the victor is expected to easily defeat the Republican challenger in the November general election, with the Cook Political Report deeming Delaware “solid” Democratic territory.
This article originally appeared on JTA.org.
The post Staunch Israel supporter Coons expected to win Delaware Democratic Senate primary handily appeared first on The Forward.
Uncategorized
Noah Wyle wins an Emmy for playing one of TV’s most Jewish doctors
(JTA) — Noah Wyle on Monday night won his second consecutive Emmy for playing Dr. Michael “Robby” Robinavitch on “The Pitt.” The win also marked a second victory for one of television’s more fully realized Jewish characters.
The actor won Outstanding Lead Actor in a Drama Series for the HBO Max medical drama, which also won Outstanding Drama Series for the second year in a row. In his acceptance speech, Wyle recalled growing up in Los Angeles and said, “This is all I’ve ever wanted to do, and this is the only club I’ve ever wanted to join.”
For Jewish viewers, the significance of Wyle’s victory goes beyond the actor’s own Jewish ancestry. In the first season, Robby was seen reciting the Shema at one of his lowest moments, turning what might have been a throwaway piece of character background into an intimate expression of fear and faith.
In the second season, Wyle, who is also a writer and executive producer on the show, pushed that dimension further. An episode he wrote dealt with the trauma of the 2018 Tree of Life synagogue shooting in Pittsburgh, while also exploring Robby’s complicated relationship with his Jewish faith.
Wyle has described Robby’s faith as something he is still “grappling” with — including the question of whether he has faith at all. The Shema scene, he said, functioned almost like a child’s primal plea for help.
Wyle was not the only Jewish winner of the night. Saul Metzstein, the Scottish Jewish director whose father was the prominent modernist architect Isi Metzstein, won Outstanding Directing for a Drama Series for “Slow Horses.” Metzstein had been competing against Wyle, who was nominated for directing an episode of “The Pitt.”
Those two wins were among the relatively few Jewish victories at this year’s ceremony. Jewish actors including Jason Segel, Lisa Kudrow, Harrison Ford and Hannah Einbinder were among the nominees but did not win in their categories.
“Nobody Wants This,” the Netflix show about a rabbi’s romance with a non-Jewish podcaster, was nominated for Outstanding Comedy Series but lost to “Widow’s Bay.”
An Emmy was also awarded to a Jewish actor and director whose death in 2025 stunned the industry and a legion of fans. Rob Reiner, who was killed in December with his wife, Michele, won a posthumous Emmy for his guest role as a kind dispenser of business advice on “The Bear.” Reiner’s award was presented at the Creative Arts Emmys earlier this month, rather than Monday’s televised ceremony.
Reiner, before going on to direct Hollywood classics like “This Is Spinal Tap,” “The Princess Bride” and “When Harry Met Sally” won his first two Emmy awards in 1974 and 1978 for playing Mike Stivic, the liberal son-in-law of Archie Bunker on “All in the Family.”
This article originally appeared on JTA.org.
The post Noah Wyle wins an Emmy for playing one of TV’s most Jewish doctors appeared first on The Forward.
Uncategorized
NAZA exposes Israel’s crisis of credibility over Gaza
More than two decades ago, when I was the The Associated Press bureau chief for Israel, the West Bank and Gaza, the Israeli military called off an attack on a senior Hamas leader after learning at the last moment that family members and children were inside the targeted building.
What stayed with me was what happened next. The military sent a senior officer to my office to explain the decision.
This was during the Second Intifada, the murderous explosion of terrorism launched by armed Palestinians after Israel had offered the Palestinian Authority an independent state in over 90 percent of the territory it sought. Hamas leaders sent suicide bombers into Israel on a daily basis to blow up buses, restaurants, malls, cafes. I checked for explosives whenever I got into my car, perhaps with my little daughters, Maya and Noa.
Yet Israeli officials understood that demonstrating concern for civilian life was part of maintaining the country’s credibility. Maybe they also thought that concern for innocent life, even on the enemy side, was the Jewish thing to do. I want to believe this, as both a Jew and as a manager who had colleagues in Gaza, some of whom were hurt over the years.
That memory returned to me amid the uproar surrounding NAZA, the new documentary by Israeli filmmakers Yuval Abraham and Rachel Szor, who shared in the 2024 Oscar for No Other Land, a critique of Israel’s practices in the West Bank.
The new film, which premiered at the Venice Film Festival and won the Special Jury Prize, is titled after the Hebrew acronym for “collateral damage” (and is also a play on “Gaza”). It examines Israel’s targeting practices in Gaza through testimony from 24 Israeli soldiers and intelligence personnel who allege the IDF used artificial intelligence.
Some of those soldiers, the filmmakers say, operated or helped design the AI systems at the center of the film. Their identities are concealed in various ways, yet their testimony portrays a disturbing picture about how technology, intelligence and estimates of civilian casualties intersected in decisions to strike.
The reaction in Israel has been ferocious. Culture Minister Miki Zohar – from the governing Likud Party led by Benjamin Netanyahu – has called the filmmakers traitors and raised the prospect of revoking their citizenship.
Former football star and prominent television personality Eyal Berkovic has similarly argued that loss of citizenship should be the best-case scenario for Israelis who harm their country. As the film moves beyond Venice, efforts to prevent its screening in Israel seem likely.
That reaction creates a sad irony. One of the strongest criticisms of NAZA is that its highly combustible testimony comes from anonymous sources – and that is a valid criticism indeed. Yet threats directed at the filmmakers offer a fairly vivid illustration of why soldiers and intelligence officers making explosive allegations about their own military might fear speaking publicly. The filmmakers say anonymity was necessary to protect people who could face serious consequences for revealing classified information. I can credibly assess they’d end up in jail.
Nonetheless, the anonymity remains a serious weakness. Claims that are this grave demand intense scrutiny, and viewers have limited means of establishing whether the witnesses held the positions they claim, possessed the knowledge they describe or represent the targeting system accurately. The IDF has challenged precisely this aspect of the film and rejected its portrayal of Israeli targeting practices.
That said, and not for the first time, the military is more reasonable than the government and the IDF’s spokesman invited the filmmakers to screen it for the military. A detailed military response to the evidence presented in NAZA would provide an essential counterweight.
The central dispute also reaches beyond whether Israel used artificial intelligence. The IDF says decisions to select and approve strikes are made by human personnel. The more consequential question is what information those people received and what weight they gave to civilian lives when making those decisions. If a system identified a Hamas operative inside a residential building, what level of civilian harm was considered acceptable in order to kill him? To what degree was AI part of the decision-making process?
Amid a global uproar over fears of AI, and in particular systems operating independently in ways that harm humans, this film catapults such questions to a very high place in the global discourse.
The AI questions lead to others. Did the permissible number of civilian casualties change according to the importance of the target? How confident did intelligence officers have to be that the intended person was actually present? What happened when information indicated that children or other family members were inside? How frequently did commanders cancel strikes because the expected civilian toll had become too high?

NAZA offers disturbing answers, and its central concern is ultimately a human one: what values and tolerances were built into the targeting process, and how were they applied by the people responsible for approving strikes?
Israel, this time around, has provided only a limited public account of those calculations during the war. Officials have emphasized the extraordinary difficulties of fighting Hamas in densely populated Gaza, the organization’s use of civilian areas for military purposes and Israeli estimates of a civilian-to-combatant casualty ratio that they say compares favorably with other episodes of urban warfare, including Mosul. The precise civilian death toll in Gaza also remains contested, particularly the division between civilians and combatants.
There is no doubt in my mind – none whatsoever – that Hamas is the embodiment of evil. It is obvious to anyone paying attention that the jihadist group engineered the entire war to maximize casualties on its own side in order to make Israel an international pariah. But it is also rather obvious by Israel’s conduct in the war and the tens of thousands of civilians who have died, that Israel to walked into the trap laid by Hamas.
Aggregate ratios tell only part of the story. They reveal little about why a particular building was struck, how many civilians were expected to be inside, what military advantage commanders anticipated or how that anticipated advantage was weighed against the likely human cost. Repeated incidents involving substantial civilian casualties have often been followed by broad explanations rather than detailed accounts of the decision-making that produced them. Foreign journalists, of course, have not been freely allowed in.
That is where my memory from more than 20 years ago feels especially relevant. The military that sent an officer to my office understood the value of a transparent process. It understood that credibility depended partly on demonstrating, in specific cases, that civilian lives carried meaningful weight in operational decisions. During the Gaza war, amid extraordinary civilian loss of life, that instinct has been far less visible, to say the least.
Why did Israel act this way? Part of it has to do with the unspeakable trauma of the Oct. 7 Hamas invasion and massacre, which left Israelis in no mood for explanations, and placed its government in a defensive posture. Part of it is the nature of that government – an ultranationalist assemblage of highly illiberal and astoundingly cynical politicians. And part of it is the global demonization targeting Israel – so thorough and unfair that it almost explains the surrender of any serious effort at PR.
None of this was smart. The resulting information vacuum has given NAZA much of its power. A documentary built substantially around anonymous testimony carries an obvious credibility burden, particularly when its allegations concern classified practices that outsiders have little ability to examine independently. Yet Israel’s sparse public accounting of its targeting decisions has left relatively little detailed evidence against which those accounts can be measured. The filmmakers have supplied one version of what happened inside the targeting system; a detailed Israeli account could provide another.
Demonizing a couple of filmmakers based on the idea that they meant to do Israel harm will not convince intelligent people and will deepen Israel’s isolation. Israel needs to explain to its own people how it failed so utterly to protect the massacre of Jews. It needs to explain to the world what went on in Gaza. In fact, it needs to explain that to its own people as well.
All of that will await another government. This will not come from Netanyahu.
The post NAZA exposes Israel’s crisis of credibility over Gaza appeared first on The Forward.

